Global Pharma Health Care Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Global Pharma Health Care Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $157.7K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Global Pharma Health Care Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $157.7K Trade | TransData Nexus

Global Pharma Health Care Private Limited

Indian Pharmaceutical Exporter · Advanced Diabetes Medications Specialist · $157.7K Total Trade · DGFT Verified

Global Pharma Health Care Private Limited is an Indian pharmaceutical exporter with a total trade value of $157.7K across 2 products in 2 therapeutic categories. Based on 6 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Vildagliptin ($150.0K), Probiotics ($7.7K), .

Global Pharma Health Care Private Limited — Export Portfolio & Destination Treemap

Global Pharma Health Care Private Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Global Pharma Health Care Private Limited? — Company Overview & Market Position

Global Pharma Healthcare Private Limited, established in 1986, is a privately held Indian pharmaceutical company headquartered in Chennai, Tamil Nadu. The company is registered under the Corporate Identification Number (CIN) U51102TN1986PTC013099. As of March 31, 2022, Global Pharma reported a paid-up capital of ₹116,009,900, with an authorized capital of ₹125,000,000. The company specializes in the export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, across various therapeutic categories.

Global Pharma's product portfolio is diverse, encompassing over 450 pharmaceutical solutions. These products are manufactured in facilities certified by the European Union Good Manufacturing Practice (EU-GMP) and the World Health Organization Good Manufacturing Practice (WHO-GMP), ensuring adherence to international quality standards. The company's manufacturing plant, located in the SIDCO Pharmaceutical Complex in Alathur, Tamil Nadu, spans over 75,000 square feet and is powered entirely by solar energy, reflecting its commitment to sustainability.

What Does Global Pharma Health Care Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Vildagliptin$150.0K

Product Portfolio — Top 2 by Export Value

Global Pharma Health Care Private Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Vildagliptin	Advanced Diabetes Medications	$150.0K	3	1.5%	12
2	Probiotics	Nutritional Supplements	$7.7K	3	0.1%	9

Global Pharma Health Care Private Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $157.7K. The top category is Advanced Diabetes Medications (95.1% of portfolio), followed by Nutritional Supplements (4.9%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Global Pharma Health Care Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Global Pharma's primary manufacturing facility is situated in the SIDCO Pharmaceutical Complex in Alathur, Tamil Nadu. This state-of-the-art plant covers more than 75,000 square feet and is designed for large-scale, precision-controlled pharmaceutical production. The facility operates entirely on solar energy, underscoring the company's dedication to sustainable manufacturing practices. It is certified by both EU-GMP and WHO-GMP, ensuring compliance with stringent international quality standards. The plant's proximity to the port of Chennai facilitates efficient logistics and distribution, enhancing the company's export capabilities.

3Key Leadership

The leadership team at Global Pharma Healthcare Private Limited is headed by Dr. A.R. Venkatesh, who serves as the Chief Executive Officer (CEO). Under his guidance, the company has expanded its global footprint, delivering pharmaceutical solutions to over 40 countries. The Chief Financial Officer (CFO) and other key executives play pivotal roles in overseeing the company's financial operations and strategic initiatives, contributing to its sustained growth and market presence.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Global Pharma Health Care Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Global Pharma Healthcare Private Limited has established a significant presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's manufacturing facilities hold certifications from EU-GMP and WHO-GMP, facilitating product registrations and approvals in these regions. In the United States, the company faced a warning letter from the FDA on October 20, 2023, citing violations of Current Good Manufacturing Practice (CGMP) regulations during an inspection conducted from February 20 to March 2, 2023. This incident underscores the importance of maintaining stringent quality control measures to ensure compliance with regulatory standards in these markets.

2Emerging Markets

Global Pharma Healthcare Private Limited has expanded its reach into emerging markets across Africa, Latin America, and Southeast Asia. The company's extensive product registrations and regulatory approvals from various Ministries of Health worldwide have facilitated its entry into these regions. Additionally, the company's WHO-GMP certification enhances its credibility and acceptance in these markets, enabling access to a broader patient base seeking affordable and high-quality pharmaceutical products.

3Geographic Strategy

Global Pharma Health Care Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Global Pharma Healthcare Private Limited's manufacturing facility in Alathur, Tamil Nadu, is registered with the U.S. Food and Drug Administration (FDA). However, the company received a warning letter from the FDA on October 20, 2023, citing violations of Current Good Manufacturing Practice (CGMP) regulations during an inspection conducted from February 20 to March 2, 2023. This warning letter highlights the need for the company to address the identified deficiencies to maintain its FDA registration and continue exporting to the U.S. market.

2WHO & EU GMP

Global Pharma Healthcare Private Limited's manufacturing facilities are certified by both the World Health Organization Good Manufacturing Practice (WHO-GMP) and the European Union Good Manufacturing Practice (EU-GMP). These certifications affirm the company's adherence to international quality standards in pharmaceutical manufacturing. The WHO-GMP certification, in particular, enhances the company's credibility in global markets, facilitating product registrations and approvals across various countries.

3CDSCO & Indian Regulatory

Global Pharma Health Care Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the pharmaceutical export sector, Global Pharma Healthcare Private Limited faces competition from both domestic and international companies. Key competitors include established Indian pharmaceutical exporters and multinational corporations with a strong presence in global markets. The company's focus on high-quality manufacturing, as evidenced by its EU-GMP and WHO-GMP certifications, positions it favorably in the market. However, the recent FDA warning letter may impact its competitive standing, necessitating prompt corrective actions to maintain market share.

2Key Differentiators

Global Pharma Healthcare Private Limited's key differentiators include its extensive product portfolio, encompassing over 450 pharmaceutical solutions across various therapeutic areas. The company's manufacturing facilities are certified by EU-GMP and WHO-GMP, ensuring adherence to international quality standards. Additionally, the facility's operation on 100% solar energy reflects a commitment to sustainability. These factors collectively contribute to the company's reputation as a reliable and quality-focused pharmaceutical exporter.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Global Pharma Health Care Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Global Pharma Healthcare Private Limited has demonstrated a consistent track record in pharmaceutical manufacturing, with a diverse product portfolio and a global presence. The company's manufacturing facility is certified by EU-GMP and WHO-GMP, ensuring adherence to international quality standards. However, the recent FDA warning letter indicates areas for improvement in quality control processes. Prospective partners should assess the company's commitment to addressing these issues and its capacity to meet supply demands reliably.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm the company's registration status with the U.S. Food and Drug Administration.

WHO-GMP Certification: Verify the World Health Organization Good Manufacturing Practice certification to ensure adherence to international quality standards.

Frequently Asked Questions — Global Pharma Health Care Private Limited

How many pharmaceutical products does Global Pharma Health Care Private Limited export from India?

Global Pharma Health Care Private Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Vildagliptin ($150.0K), Probiotics ($7.7K). Total export value is $157.7K.

What is Global Pharma Health Care Private Limited's total pharmaceutical export value?

Global Pharma Health Care Private Limited's total pharmaceutical export value is $157.7K, based on 6 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Global Pharma Health Care Private Limited cover?

Global Pharma Health Care Private Limited exports across 2 therapeutic categories. The largest are Advanced Diabetes Medications (95.1%, 1 products), Nutritional Supplements (4.9%, 1 products).

Get Full Global Pharma Health Care Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.